Demichel P, Gomond P, Roquebert J
Br J Pharmacol. 1982 Nov;77(3):449-54. doi: 10.1111/j.1476-5381.1982.tb09317.x.
1 Raubasine was compared with yohimbine and corynanthine in pithed rats. Antagonist activity at alpha 1-adrenoceptors was evaluated on the pressor response to electrical stimulation of the spinal sympathetic outflow and to phenylephrine administration, both being reduced by raubasine in the dose range 1 to 4 mg/kg. Corynanthine was quantitatively similar, but yohimbine was not only less potent but also in doses of 0.125 to 0.5 mg/kg enhanced the effects of electrical stimulation. 2 Antagonist activity at alpha 2-adrenoceptors was determined against the inhibitory effects of clonidine on tachycardia induced by electrical stimulation of cardiac sympathetic nerves and against the pressor responses to B-HT-933 injection. Raubasine up to 4 mg/kg, like corynanthine, did not affect the pressor responses to B-HT-933 nor did it reduce the inhibitory effect of clonidine. By contrast yohimbine reduced the response to BHT-933 and antagonized clonidine as well as enhancing the tachycardia caused by electrical stimulation. 3 The results indicate that, in vivo, raubasine, like corynanthine, is a selective antagonist at alpha 1-adrenoceptors and that yohimbine is more potent in blocking alpha 2-than alpha 1-adrenoceptors.
1 在脊髓麻醉大鼠中,将萝巴新与育亨宾和柯楠碱进行了比较。通过对脊髓交感神经传出纤维电刺激和给予去氧肾上腺素后的升压反应来评估α1 - 肾上腺素受体的拮抗活性,在1至4毫克/千克的剂量范围内,萝巴新都能降低这两种反应。柯楠碱在数量上与之相似,但育亨宾不仅效力较低,而且在0.125至0.5毫克/千克的剂量下会增强电刺激的效果。2 通过可乐定对心脏交感神经电刺激诱发的心动过速的抑制作用以及对B - HT - 933注射后的升压反应来测定α2 - 肾上腺素受体的拮抗活性。高达4毫克/千克的萝巴新,与柯楠碱一样,不影响对B - HT - 933的升压反应,也不降低可乐定的抑制作用。相比之下,育亨宾降低了对BHT - 933的反应,拮抗了可乐定,同时增强了电刺激引起的心动过速。3 结果表明,在体内,萝巴新与柯楠碱一样,是α1 - 肾上腺素受体的选择性拮抗剂,而育亨宾阻断α2 - 肾上腺素受体比阻断α1 - 肾上腺素受体更有效。